Armata Pharmaceuticals (ARMP) Shares Outstanding (2016 - 2026)

Armata Pharmaceuticals has reported Shares Outstanding over the past 14 years, most recently at $36.6 million for Q1 2026.

• Shares Outstanding reached $36.6 million in Q1 2026 per ARMP's latest filing, up from $36.4 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $36.6 million in Q1 2026 and bottomed at $36.1 million in Q1 2022.
• Median Shares Outstanding over the past 5 years was $36.1 million (2022), compared with a mean of $36.2 million.
• The largest annual shift saw Shares Outstanding skyrocketed 44.87% in 2022 before it fell 0.06% in 2023.
• Over 5 years, Shares Outstanding stood at $36.1 million in 2022, then dropped by 0.06% to $36.1 million in 2023, then grew by 0.17% to $36.2 million in 2024, then grew by 0.69% to $36.4 million in 2025, then rose by 0.59% to $36.6 million in 2026.
• Business Quant data shows Shares Outstanding for ARMP at $36.6 million in Q1 2026, $36.4 million in Q4 2025, and $36.2 million in Q3 2025.

Peer Comparison